Free Trial

Leaning Towards No-Deal Today

US TSYS SUMMARY

Markets buffeted by deal/no-deal stimulus headlines during second half. White House Speaker Pelosi remained optimistic, Sen Shelby expressed no optimism of a deal, while Sen Mitt Romney flat-out opposing $1.8T deal (or more) adding to late sales in equities. Stanza: Sen majority leader McConnell said would hold vote for stimulus if deal reached, vote does not mean pass.

  • Astrazeneca vaccine trial to resume in a few days likely contributed to the midday bid in equities. Other salient headlines:
  • GOOGLE ACCUSED BY U.S. OF ABUSING MARKET POWER IN LANDMARK CASE, Bbg
  • BREXIT - UK PM JOHNSON TELLS GREEK PM: EU HAVE EFFECTIVELY ENDED NEGS, Rtrs
  • Little to no react to multiple Fed speakers, Chicago Fed Pres Evans said stepping up asset purchases would have limited effect on already-low borrowing costs now, but the Fed could consider offering further accommodation later in the recovery.
  • Trade volumes were about average, TYZ>1.1M after the bell, two-way flow from fast$, prop and bank portfolios in short end.
  • The 2-Yr yield is down 0.2bps at 0.1431%, 5-Yr is up 0.2bps at 0.3361%, 10-Yr is up 2.2bps at 0.7907%, and 30-Yr is up 3.8bps at 1.5976%.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.